January 16th 2025
The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Delve into the current state of prescription digital therapeutics (PDTs) adoption and uncover strategies for increasing payer approval and achieving widespread coverage of PDTs.
Researchers Share Insights From Patients Enrolled in Innovative PAH Repository
July 28th 2023Called the TRIO comprehensive, integrated patient data repository (TRIO CIPDR), the unique registry combines clinical data from electronic health records with pharmacy data, including PAH-specific drugs prescribed, as well as the dates prescribed, administered, and refilled.
Read More
Frequent Smokers Ambivalent About Quitting May Be More Receptive to Tailored Interventions
July 11th 2023This small study showed that individuals who used an app designed specifically for smokers ambivalent about quitting used the app more often and exhibited greater changes in behavior compared with those using a similar nontailored app.
Read More
Economics of a Health System’s Direct-to-Consumer Telemedicine for Its Employees
A direct-to-consumer telemedicine service resulted in lower per-episode unit costs for care within 7 days and only marginally increased the use of services overall.
Read More
Financial Factors That Influenced Telemedicine Delivery During the COVID-19 Pandemic
This study describes financial issues that influenced telemedicine provision and use for patients with chronic conditions and their providers during COVID-19.
Read More
The Value of Virtual Physical Therapy for Musculoskeletal Care
This counterfactual simulation study on a nationally representative sample of the working population with musculoskeletal conditions estimated the value of patient-initiated virtual physical therapy.
Read More
Dr Sheila Garland: CBT for Insomnia Improves Functioning in Patients With Cancer
June 7th 2023Targeting insomnia with cognitive behavior therapy is almost like a frontline therapy, because by doing so, you’re able to improve a whole host of other symptoms that would coexist with insomnia, explained Sheila Garland, PhD, MSc, Memorial University in Newfoundland, Canada.
Watch
Digitally Tracked Data Improve QOL in Autoimmune Diseases, Long COVID
May 30th 2023Quality of life (QOL) for people living with autoimmune diseases benefits from an integrated approach that considers individual immune system sensitivities and patients’ life circumstances, a new study shows.
Read More